Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Association of Anti-Mullerian Hormone on Oocyte Maturation, Fertilization, and Pregnancy Rates in Patients Under Assisted Reproductive Technology Cycles: A Cross-Sectional Study Publisher



Hafezi SG1, 2 ; Ghorbanzadeh M3 ; Rahaghi BH4 ; Rezvaniyan F5 ; Forghani N5 ; Shafiean M6 ; Aghadavood F7 ; Lawrence Beeson W8 ; Ghamsary M8
Authors

Source: International Journal of Fertility and Sterility Published:2024


Abstract

Background: Ovarian reserve is one of the most important factors that influences the success of assisted reproductive technology (ART). Recently, the role of anti-mullerian hormone (AMH) in ART has been investigated as a marker for the prediction of ovarian response. We aim to examine this relationship within a large Iranian population. Materials and Methods: In this cross-sectional study, we obtained data from 1000 infertile couples who referred to the Research and Clinical Centre of Yazd Infertility Clinic for in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). Serum AMH levels, oocyte count, numbers of fertilised oocytes, endometrial thickness, and percentage of mature oocytes were measured. The relationship between AMH serum levels and the number and quality of oocytes and embryos in ART cycles was analysed. Results: In the linear regression model, the log of the variables total dose of gonadotropin, two pronuclei (2PN), log oestradiol, total embryos, duration of stimulation, number of embryos transferred, protocol, and cause of infertility were significant predictors of log AMH. Conclusion: There appears to be a relationship between serum AMH levels in the early follicular phase and ovarian reserve. Higher serum AMH levels were also associated with shorter ART cycles. © 2024, Royan Institute (ACECR). All rights reserved.
Other Related Docs
15. Factors Associated With In-Vitro Fertilization Success in Polycystic Ovary Syndrome, Journal of Obstetrics, Gynecology and Cancer Research (2024)